Literature DB >> 12097789

Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?

Mauro G Carta1, Paolo Serra, Assunta Ghiani, Elisabetta Manca, Maria Carolina Hardoy, Gennaro S Del Giacco, Giacomo Diaz, Bernardo Carpiniello, Paolo E Manconi.   

Abstract

BACKGROUND: People with Down's syndrome (DS) show early Alzheimer-like dementia. It has been suggested that the pro-inflammatory cytokine class plays a role in Alzheimer's disease (AD). The study aims at verifying whether pro-inflammatory cytokines in DS are correlated with age, affective symptoms and intellectual decline to a different degree than in subjects with non-DS learning disabilities. CASES: 19 subjects with DS; controls: sex- and age-matched individuals with learning disabilities caused by perinatal ischaemic damage. The level of mental retardation was assessed according to DSM-IV; psychopathological symptoms were measured by the Assessment and Information Rating Profile. Serum levels of cytokines were determined with ELISA.
RESULTS: DS patients showed higher levels of cytokines and chemokines, with the exception of RANTES; but the only significant difference detected was for MIP-1alpha. A correlation between the degree of mental retardation and IL-6, and between MIP-lalpha and age was found in patients with DS, but not in controls.
CONCLUSIONS: The data obtained suggest a possible involvement of chemokines in the inflammatory and degenerative processes similar to AD in DS. Further longitudinal research is required to confirm these findings. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097789     DOI: 10.1159/000063649

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  14 in total

1.  RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons.

Authors:  Alma Sanchez; Debjani Tripathy; Paula Grammas
Journal:  Neuropeptides       Date:  2009-06-03       Impact factor: 3.286

2.  Purkinje neuron physiology is altered by the inflammatory factor interleukin-6.

Authors:  Donna L Gruol; Thomas E Nelson
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 3.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

4.  An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report.

Authors:  Grace E Weber; Katherine A Koenig; Maria Khrestian; Yvonne Shao; Elizabeth D Tuason; Marie Gramm; Dennis Lal; James B Leverenz; Lynn M Bekris
Journal:  J Immunol       Date:  2020-01-20       Impact factor: 5.422

Review 5.  Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease.

Authors:  Farida El Gaamouch; Kalena Liu; Hsiao-Yun Lin; Clark Wu; Jun Wang
Journal:  Neurochem Int       Date:  2021-04-16       Impact factor: 4.297

6.  Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS).

Authors:  Giles My Tan; Felix Beacher; Eileen Daly; Jamie Horder; Verinder Prasher; Maria-Luisa Hanney; Robin Morris; Simon Lovestone; Kieran C Murphy; Andrew Simmons; Declan Gm Murphy
Journal:  J Neurodev Disord       Date:  2014-11-27       Impact factor: 4.025

7.  Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Alzheimer's Disease via Enhancing Neuron Differentiation and Paracrine Action.

Authors:  Guo-Hong Cui; Shui-Jin Shao; Jia-Jun Yang; Jian-Ren Liu; Hai-Dong Guo
Journal:  Mol Neurobiol       Date:  2015-01-14       Impact factor: 5.590

8.  Prevalence of celiac disease in patients with Down syndrome: a meta-analysis.

Authors:  Yang Du; Ling-Fei Shan; Zong-Ze Cao; Jin-Chao Feng; Yong Cheng
Journal:  Oncotarget       Date:  2017-12-23

Review 9.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

10.  Epidemiology of early-onset dementia: a review of the literature.

Authors:  Renata Teles Vieira; Leonardo Caixeta; Sergio Machado; Adriana Cardoso Silva; Antonio Egidio Nardi; Oscar Arias-Carrión; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.